DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Galmed Pharmaceuticals Ltd. (GLMD)
« Back to company indexGLMD Chatter Timeline
Stock Ticker for GLMD
Most Active Tweeters for GLMD
| User | Tweets |
|---|---|
| @thefinreviewer | 6 |
| @bibeypost_stock | 4 |
| @bulletin_en | 4 |
| @BlogYomi | 3 |
| @whatsonthorold2 | 3 |
Recent Tweets for GLMD
 |
@BlogYomi United Therapeutics Corporation $GLMD Comparison side by side https://t.co/kZm57MS9TJ April 18th 2019, 10:04pm |
 |
@bibeypost_stock Are Analysts Bullish Galmed Pharmaceuticals Ltd. $GLMD After Last Week? https://t.co/7Afa3iaXIF April 18th 2019, 4:04pm |
 |
@SwingTradeBot 50 DMA Resistance today: $GLMD ... https://t.co/mnYaiRq1wk April 18th 2019, 3:04pm |
 |
@thefinreviewer Galmed Pharmaceuticals LTD $GLMD Valuation Declined While Bvf Raised Stake; High Pointe Capital Management Continue… https://t.co/EkMu89K9Jb April 18th 2019, 9:04am |
 |
@JonathanWexler3 $GLMD Sense of Urgency? Check. Highly safe? Check. Global trials? Not sure those are cheaper. Definitely less re… https://t.co/yVoWCTMYQ1 April 17th 2019, 1:04pm |
 |
@UlmHi Galmed P $GLMD Valuation Declined While Ubs Oconnor Has Trimmed Its Stake; As Aspen Insurance Holdings LTD $AHL Sto… https://t.co/LzVDAbHEnK April 17th 2019, 11:04am |
|
@BlogYomi Pacific Biosciences of California Inc. $GLMD https://t.co/V2Jqm0QQDC April 17th 2019, 12:04am |
|
@thefinreviewer Comparing of Cyanotech Corporation $GLMD https://t.co/hJjH4Kw0rc April 14th 2019, 8:04pm |
 |
@bulletin_en Reviewing Mesoblast Limited $GLMD's results https://t.co/uqXRmsmpZf April 14th 2019, 4:04pm |
 |
@mmahotstuff1 BidaskScore Decides to Downgrade Galmed Pharmaceuticals $GLMD. Will Other Analysts Follow? https://t.co/x3PKbaHGam April 14th 2019, 12:04am |
 |
@whatsonthorold2 Galmed Pharmaceuticals $GLMD Seems to Be a Stock That BidaskScore Is a Bit Wary of; Firm Downgrades Shares https://t.co/wLg9rrgEeO April 14th 2019, 12:04am |
|
@bibeypost_stock Analysts at BidaskScore Give Galmed Pharmaceuticals $GLMD a Downgrade https://t.co/NmBUvXRCKh April 14th 2019, 12:04am |
 |
@reurope_stock Galmed Pharmaceuticals $GLMD Receives a Lower Rating From BidaskScore. Is it Time to Sell Shares? https://t.co/lPfdnhz1s6 April 14th 2019, 12:04am |
|
@thefinreviewer Reviewing Achillion Pharmaceuticals Inc. $GLMD's results https://t.co/uo2I4QEwQU April 13th 2019, 9:04pm |
|
@UlmHi As Galmed Pharmaceuticals LTD $GLMD Stock Value Declined, Bvf Has Upped Its Stake; Bank Of New York Mellon Has Uppe… https://t.co/xHw0GZolG1 April 11th 2019, 8:04am |
|
@bulletin_en Comparing of Synlogic Inc. $GLMD https://t.co/g2lxiQHLa6 April 11th 2019, 3:04am |
|
@thefinreviewer Reviewing Nektar Therapeutics $GLMD's results https://t.co/m72XNkFDf0 April 10th 2019, 9:04pm |
 |
@ChartMill $GLMD has only a medium technical rating, but it does show a decent setup pattern. https://t.co/IXEQ73mWvS https://t.co/gOhKqBdDwt April 10th 2019, 8:04pm |
|
@BlogYomi Contrasting of Pieris Pharmaceuticals Inc. $GLMD https://t.co/VAHVevkDZQ April 10th 2019, 1:04pm |
 |
@Miljenkoz $GLMD https://t.co/uq60pK6v16 General agreement has been reached with FDA on key aspects of the ARMOR study includ… https://t.co/lMnChmCPSi April 9th 2019, 4:04pm |
 |
@StockNewsNow $GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start… https://t.co/qPkuetwtJX April 9th 2019, 11:04am |
 |
@Stock_News_Now $GLMD: New SEC Filing for GLMD: Form 6-K (No. 0001144204-19-018741): https://t.co/J8Bf87NEwb April 9th 2019, 9:04am |
 |
@tradnews_ RT @OpenOutcrier: $GLMD (+7.1% pre) Galmed Pharma Reports Complete End of Phase 2 Meeting with FDA and Plan for Start of Phase 3 https://t… April 9th 2019, 8:04am |
 |
@OpenOutcrier $GLMD (+7.1% pre) Galmed Pharma Reports Complete End of Phase 2 Meeting with FDA and Plan for Start of Phase 3 https://t.co/ujrSuWv7kR April 9th 2019, 8:04am |
 |
@okim59 Galmed readies pivotal study of NASH candidate Aramchol $GLMD https://t.co/f0us9UYF2c April 9th 2019, 8:04am |
 |
@newswithvalue $GLMD: Galmed readies pivotal study of NASH candidate Aramchol: https://t.co/kbUkHueN44 April 9th 2019, 8:04am |
 |
@StockTexts $GLMD Galmed Pharmaceuticals Ltd. SEC Filing: Form 6-K https://t.co/j85vGROo9o April 9th 2019, 8:04am |
 |
@confcalltran Galmed Pharmaceuticals Announces Successful Completion Of https://t.co/91x72e7kSg $GLMD April 9th 2019, 8:04am |
 |
@MarketCurrents $GLMD - Galmed readies pivotal study of NASH candidate Aramchol https://t.co/YaOvUhALDn April 9th 2019, 8:04am |
 |
@Hall8Jack RT @BioStocks: $GLMD Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3 https://t.co/PJFzOISq… April 9th 2019, 7:04am |
 |
@biostockinfo RT @TraderTexMex: $GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Pha… April 9th 2019, 7:04am |
|
@newswithvalue $GLMD: Galmed Pharmaceuticals Announces Successful Completion of End …: https://t.co/bfRaMCVLnp April 9th 2019, 7:04am |
 |
@bthefirsttoknow $GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start… https://t.co/MQ9NuU8cQb April 9th 2019, 7:04am |
 |
@RSIDayTrader good thing $GLMD didn't fail or have setbacks w this end of ph2 mtg with FDA.. helpful PR April 9th 2019, 7:04am |
 |
@TraderTexMex $GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3 April 9th 2019, 7:04am |
 |
@BioStocks $GLMD Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3 https://t.co/PJFzOISqVi April 9th 2019, 7:04am |
|
@thefinreviewer Seres Therapeutics Inc. $GLMD Comparing side by side https://t.co/zhnZw10PUu April 9th 2019, 1:04am |
|
@whatsonthorold2 This is what analysts have to say about Galmed Pharmaceuticals Ltd. $GLMD after last week. https://t.co/tTnSjvvnRb April 8th 2019, 2:04pm |
|
@bibeypost_stock Are Analysts Bullish Galmed Pharmaceuticals Ltd. $GLMD After Last Week? https://t.co/Z24aoQ2zH0 April 8th 2019, 2:04pm |
|
@reurope_stock Analysts are on the Bearish side about Galmed Pharmaceuticals Ltd. $GLMD this week. https://t.co/xrCc3hqxkb April 8th 2019, 2:04pm |
|
@bulletin_en Weekly Galmed Pharmaceuticals Ltd. $GLMD Ratings as of Apr 8, 2019 https://t.co/V3fMo4Ufmo April 8th 2019, 1:04pm |
|
@whatsonthorold2 It Seems Galmed Pharmaceuticals LTD. - Ordinary Shares $GLMD Will Go Down. Just Reported More Shorted Shares https://t.co/P3f4daf8Vc April 8th 2019, 11:04am |
|
@bibeypost_stock After Reaching Milestone, Is Galmed Pharmaceuticals LTD. - Ordinary Shares $GLMD’s Short Interest Revealing Somethi… https://t.co/1POi4xjEZh April 8th 2019, 11:04am |
|
@bulletin_en LogicBio Therapeutics Inc. $GLMD Comparing side by side https://t.co/A5F44f44Sr April 8th 2019, 12:04am |
|
@dakotafinancial Galmed Pharmaceuticals Ltd $GLMD Receives $36.86 Consensus PT from Brokerages https://t.co/yvgPcLhaV3 April 6th 2019, 11:04pm |
 |
@macondailynews Galmed Pharmaceuticals Ltd $GLMD Receives Average Rating of “Buy” from Brokerages https://t.co/4KQbcQ1SUV April 6th 2019, 11:04pm |
|
@thefinreviewer Reviewing Auris Medical Holding AG $GLMD's results https://t.co/AgTLDgujuj April 6th 2019, 9:04pm |
|
@macondailynews Zacks: Brokerages Anticipate Galmed Pharmaceuticals Ltd $GLMD to Announce -$0.19 EPS https://t.co/YWFtPrnxWf April 6th 2019, 9:04pm |
 |
@TheMarketsDaily Galmed Pharmaceuticals Ltd $GLMD Expected to Announce Earnings of -$0.19 Per Share https://t.co/u2PwCo6TFm April 6th 2019, 9:04pm |
 |
@WatchlistN Brokerages Expect Galmed Pharmaceuticals Ltd $GLMD Will Post Quarterly Sales of $230,000.00 https://t.co/UH5157gRkq April 6th 2019, 9:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.